Results 81 to 90 of about 364,790 (104)

Outer membrane vesicles as versatile tools for therapeutic approaches. [PDF]

Microlife, 2021
Zingl FG, Leitner DR, Thapa HB, Schild S.   +3 more
europepmc   +1 more source

Development of a GMMA-based candidate vaccine against invasive nontyphoidal <i>Salmonella</i> disease. [PDF]

Front Immunol
Citiulo F, Koeberling O, Rossi O, Cappelletti E, Giannelli C, Aruta MG, De Simone D, Pippi F, Ferhati X, De Felice A, Acquaviva A, Daniele A, De Luca F, Iannello G, Vitali CG, Necchi F, Martin LB, Berlanda Scorza F, Colucci AM, Canals R.   +19 more
europepmc   +1 more source

Outer membrane vesicles as a versatile nanoplatform for advanced vaccine development and immunotherapy. [PDF]

Front Immunol
Zhang J, Zhi Y, Lu Y, Ma F.
europepmc   +1 more source

Vaccines as Potential Frontliners Against Antimicrobial Resistance (AMR): A Focused Review. [PDF]

Infect Drug Resist
Patil S, Singh I, Verma IK, Kumar A, Sharma J, Ratn A, Dhakad MS, Sharma D.   +7 more
europepmc   +1 more source

Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives. [PDF]

Vaccines (Basel)
Zahid A, Ismail H, Wilson JC, Grice ID.
europepmc   +1 more source

The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentations. [PDF]

Vaccine
Banerjee S, Barry EM, Baqar S, Louis Bourgeois A, Campo JJ, Choy RKM, Chakraborty S, Clifford A, Deal C, Estrada M, Fleckenstein J, Hasso-Agopsowicz M, Hausdorff W, Khalil I, Maier N, Mubanga C, Platts-Mills JA, Porter C, Qadri F, Simuyandi M, Walker R, White JA.   +21 more
europepmc   +1 more source

Evaluation of a Quadrivalent Shigella flexneri Serotype 2a, 3a, 6, and Shigella sonnei O-Specific Polysaccharide and IpaB MAPS Vaccine. [PDF]

Vaccines (Basel)
Boerth EM, Gong J, Roffler B, Hancock Z, Berger L, Song B, Malley SF, MacLennan CA, Zhang F, Malley R, Lu YJ.   +10 more
europepmc   +1 more source

Prevalence of Shigella species and antimicrobial resistance patterns in Africa: systematic review and meta-analysis. [PDF]

BMC Infect Dis
Nyarkoh R, Odoom A, Donkor ES.
europepmc   +1 more source

Outer Membrane Vesicle Vaccine Platforms. [PDF]

BioDrugs
Micoli F, Adamo R, Nakakana U.
europepmc   +1 more source

Shigella-Controlled Human Infection Models: Current and Future Perspectives. [PDF]

Curr Top Microbiol Immunol
Clarkson KA, Porter CK, Talaat KR, Kapulu MC, Chen WH, Frenck RW, Bourgeois AL, Kaminski RW, Martin LB.   +8 more
europepmc   +1 more source